These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 3140211

  • 1. Serum interferon concentrations and retroviral serology in Kawasaki syndrome.
    Rowley AH, Shulman ST, Preble OT, Poiesz BJ, Ehrlich GD, Sullivan JR.
    Pediatr Infect Dis J; 1988 Sep; 7(9):663-6. PubMed ID: 3140211
    [No Abstract] [Full Text] [Related]

  • 2. [Kawasaki mucocutaneous lymph node syndrome. 3 cases].
    Estavoyer JM, Boichard D, Folschweiller B, Baufle GH, Debrand J, Perat R.
    Nouv Presse Med; 1979 Sep 24; 8(36):2908. PubMed ID: 493102
    [No Abstract] [Full Text] [Related]

  • 3. [Development of Kawasaki disease and the initial infection by EB virus].
    Kikuta H, Mizuno F, Osato T, Konno M, Ishikawa N, Nanbu H, Anakura M, Oka Y, Matsumoto S, Noro S.
    Nihon Rinsho; 1983 Sep 24; 41(9):2069-74. PubMed ID: 6319775
    [No Abstract] [Full Text] [Related]

  • 4. Potential impact of AUSFTA on Australia's blood supply.
    Kennedy GA, Cummings J, Durrant ST.
    Med J Aust; 2007 Apr 16; 186(8):427; author reply 430. PubMed ID: 17437402
    [No Abstract] [Full Text] [Related]

  • 5. Development of coronary artery lesions in Kawasaki disease patients in relation to plasma interferon-gamma and interleukin-4 [corrected] levels in the acute phase.
    Hirao J, Nagayoshi I.
    Acta Paediatr Jpn; 1997 Apr 16; 39(2):293-5. PubMed ID: 9141276
    [No Abstract] [Full Text] [Related]

  • 6. Recurrent mucocutaneous lymph node syndrome (Kawasaki disease): a report of three cases.
    Keren G, Passwell J, Cohen BE.
    J Med; 1986 Apr 16; 17(5-6):365-71. PubMed ID: 3473170
    [Abstract] [Full Text] [Related]

  • 7. Superantigens and Kawasaki disease.
    Furukawa S, Matsubara T, Yabuta K.
    Immunol Today; 1991 Dec 16; 12(12):464. PubMed ID: 1786081
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Plasma prostaglandin E2 and F2 alpha levels in patients with mucocutaneous lymph node syndrome (Kawasaki disease) and anaphylactoid purpura].
    Lee T.
    Arerugi; 1985 Mar 16; 34(3):147-54. PubMed ID: 3862369
    [No Abstract] [Full Text] [Related]

  • 10. T-cell subsets in Kawasaki syndrome.
    Marchette NJ, Melish ME, Kihara S, Caplan F, Ching D.
    Prog Clin Biol Res; 1987 Mar 16; 250():545-6. PubMed ID: 3501128
    [No Abstract] [Full Text] [Related]

  • 11. [Autoantibodies in patients with mucocutaneous lymph node syndrome (Kawasaki disease)].
    Saji T, Umezawa T, Hashiguchi R, Matsuo N.
    Arerugi; 1983 Dec 16; 32(12):1129-33. PubMed ID: 6678147
    [No Abstract] [Full Text] [Related]

  • 12. Spirochaetal studies in Kawasaki syndrome.
    Marchette NJ, Melish ME, James JF, Kihara S, Caplan F.
    Prog Clin Biol Res; 1987 Dec 16; 250():87-99. PubMed ID: 3423085
    [No Abstract] [Full Text] [Related]

  • 13. Leukoerythroblastosis in Kawasaki disease.
    Sills RH, Cruz L.
    Am J Pediatr Hematol Oncol; 1985 Dec 16; 7(2):193-6. PubMed ID: 3842564
    [No Abstract] [Full Text] [Related]

  • 14. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
    Kwon SY, Lim AH, Park JY, Han SH, Cho NS.
    J Med Virol; 2008 Oct 16; 80(10):1864-7. PubMed ID: 18712809
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of Kawasaki syndrome by intravenous gamma globulins. A medium-term clinical and paraclinical study of 5 cases].
    Lebranchu Y, Despert F, Borderon JC, Bloc D, Renoux M, Bardos P, Laugier J.
    Ann Pediatr (Paris); 1986 Nov 16; 33(9):809-13. PubMed ID: 3492169
    [No Abstract] [Full Text] [Related]

  • 16. Aetiology of Kawasaki disease.
    Bannister BA, Edwards S, Ibata G.
    Arch Dis Child; 1989 Mar 16; 64(3):397-8. PubMed ID: 2539788
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Histiocytic haemophagocytosis in a patient with Kawasaki disease: changes in the hypercytokinaemic state.
    Ohga S, Ooshima A, Fukushige J, Ueda K.
    Eur J Pediatr; 1995 Jul 16; 154(7):539-41. PubMed ID: 7556319
    [Abstract] [Full Text] [Related]

  • 19. Absence of interferon in sera of patients with Kawasaki syndrome.
    Ogle JW, Waner JL, Joffe LS, Brogden RL, Wiggins J, Glode MP.
    Pediatr Infect Dis J; 1991 Jan 16; 10(1):25-9. PubMed ID: 1706091
    [Abstract] [Full Text] [Related]

  • 20. Immune complexes in Kawasaki syndrome: a review.
    Pachman LM, Herold BC, Davis AT, Hang LM, Schaller JG, Beckwith B, Arroyave CM, Gawryl MS, Lint T, Shulman ST.
    Prog Clin Biol Res; 1987 Jan 16; 250():193-207. PubMed ID: 3321076
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.